SCHEMBL23940764

SCHEMBL23940764

CCc1cc(O)c(=O)oc1-c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.42
TYR P14679 1/20 0.42
DAO P14920 1/20 0.42
AKR1B1 P15121 1/20 0.42
ADORA3 P0DMS8 4/20 0.41
MEN1 O00255 7/20 0.40
KMT2A Q03164 7/20 0.40
CYP3A4 P08684 6/20 0.40
MAPT P10636 4/20 0.40
ADORA2A P29274 3/20 0.40
ABCB1 P08183 3/20 0.40
CYP2C19 P33261 3/20 0.40
CYP2C9 P11712 2/20 0.40
POLB P06746 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
CA12 O43570 2/20 0.40
CYP1B1 Q16678 2/20 0.40
CYP1A1 P04798 1/20 0.40
CYP1A2 P05177 1/20 0.40
BCHE P06276 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23925955 0.79 HPGD (0.44) HPGDTYRDAOAKR1B1ADORA3
SCHEMBL4348247 0.75 KDM4E (0.50) HPGDADORA3MEN1KMT2ACYP3A4
SCHEMBL23925819 0.71 KDM4E (0.40) HPGDMEN1KMT2ACYP3A4MAPT
SCHEMBL23925781 0.70 MEN1 (0.39) HPGDADORA3MEN1KMT2ACYP3A4
SCHEMBL9066203 0.69 BACE1 (0.64) HPGDPOLBSMN1; SMN2RECQLALDH1A1
SCHEMBL29287975 0.68 CNR2 (0.44) DAOPOLBSMN1; SMN2RECQLKDM4E
SCHEMBL23926072 0.68 BACE1 (0.50) HPGDMEN1KMT2APOLBSMN1; SMN2
SCHEMBL23940763 0.68 KDM4E (0.37) HPGDADORA3MEN1KMT2ACYP3A4
SCHEMBL23925729 0.67 BCL2 (0.45) HPGDMEN1KMT2ACYP3A4MAPT
SCHEMBL10869318 0.67 MEN1 (0.50) HPGDADORA3MEN1KMT2ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230117370-A1 REGIOSELECTIVE SYNTHESIS OF SUBSTITUTED COMPOUNDS OREGON STATE UNIVERSITY (US) 2023-04-20 US disclosed
US-20230117370-A1 REGIOSELECTIVE SYNTHESIS OF SUBSTITUTED COMPOUNDS OREGON STATE UNIVERSITY (US) 2023-04-20 US disclosed
WO-2021211982-A2 REGIOSELECTIVE SYNTHESIS OF SUBSTITUTED COMPOUNDS OREGON STATE UNIVERSITY (US) 2021-10-21 WO disclosed
WO-2021211982-A2 REGIOSELECTIVE SYNTHESIS OF SUBSTITUTED COMPOUNDS OREGON STATE UNIVERSITY (US) 2021-10-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230117370-A1 REGIOSELECTIVE SYNTHESIS OF SUBSTITUTED COMPOUNDS CYP2B6, TYR, CYP2D6 HPGD 683/4885TYR 2/4885DAO 175/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.